Sign in
Taking people in United StatesPhase 1/2

Intranasal Insulin for Treatment of Alcohol Use Disorder

Key facts

Who runs it
Brown University
Where
Providence, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1/2
People taking part
40 people, planned
Started
25 Feb 2025
Expected to end
31 Jan 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Regular Human Insulin then Placebo
  • Placebo then Regular Human Insulin
Record updated
30 September 2026

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (2)Hide the full registry criteria

Who can take part

  • ≥21 years; meet any DSM-5 criteria score for AUD; Individuals who, in the last month, have consumed at least the same amount of alcohol that will be administered in the laboratory procedure (i.e. to reach BrAC levels of 0.08g/dl, ~two drinks in one occasion); BrAC=0.00g/dL at each visit; good health as confirmed by medical history, physical examination and lab tests; willing to adhere to the study procedures; understand informed consent and questionnaires in English at an 8th grade level; willing to have glucose monitored by finger stick during the laboratory procedures

Who cannot take part

  • • female identifying who are breastfeeding or pregnant (assessed by a urine screen); individuals with diabetes; history of suicide attempts in the last three years; current diagnosis of other substance use disorder (other than nicotine or cannabis); use of drugs (e.g. stimulants/opioids) at each alcohol administration session (by urine tox screen); cannabis intoxication (by clinical assessments); use of medications that may interact with insulin and alcohol (by Micromedex database); hypersensitivity to insulin; any nasal disease/congestion that may interfere with intranasal drug absorption; baseline hypoglycemia (blood glucose ≤65mg/dL) or hyperglycemia (blood glucose >200mg/dL) (by finger stick)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Alcohol use disorder

This trial is currently available in United States.

  • Brown UniversityProvidence, United StatesContact: Zoe BrownTaking people

About the trial

What the trial wants to find out

This is a randomized controlled trial (RCT), within-subject, crossover, double-blind, placebo-controlled in non-treatment-seeking individuals with Alcohol Use Disorder (AUD) (N=40, 50% female) randomized to IN insulin or placebo. In a bar laboratory setting, randomized participants will receive a single dose of IN insulin (80IU) or an IN matched placebo (0.9% Saline). Participants will undergo a cue-reactivity paradigm followed by an alcohol challenge that includes an alcohol drink designed to raise the breath alcohol content (BrAC) to 0.08g/dL.

The 2 groups in the trial

  • Insulin, Then PlaceboTreatment being tested

    There will be one single administration of intranasal human insulin (80IU) before alcohol self-administration. After a one week washout period, there will be one single intranasal administration of placebo (saline, 0.9% solution) before alcohol self administration.

    Treatment: Regular Human Insulin then Placebo

  • Placebo, Then InsulinTreatment being tested

    There will be one single intranasal administration of placebo (saline, 0.9% solution) before alcohol self administration. After a one week washout period, there will be one single administration of intranasal human insulin (80IU) before alcohol self-administration.

    Treatment: Placebo then Regular Human Insulin

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05988632, who can take part
Publications
Record updated
30 September 2026